|
Hakan Mellstedt M.D. Ph.D. is Professor of Oncologic Biotherapy at the Karolinska Institute and Administrative Director of Cancer Center Karolinska Karolinska Institute Stockholm Sweden. He holds a position as Chief Physician at the Department of Oncology (Radiumhemmet) Karolinska Hospital Stockholm and has specialist certificates in Oncology Hematology and Internal Medicine. He is the Chairman of the Swedish Society of Oncology. Professor Mellstedt is currently a member of the Editorial Board of several international scientific journals and has published more than 375 articles in the areas of hematology medical oncology tumor immunology and the development of immunotherapeutics/biotherapeutics in hematological malignancies as well as in solid tumors. Professor Mellstedt is the Chairman of OXiGENE's Clinical Trial Advisory Board. | 